Cargando…

Letter re: Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study

Detalles Bibliográficos
Autores principales: Zhang, J., Liu, L., Wang, G., Zhao, K., Guo, C., Li, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512834/
https://www.ncbi.nlm.nih.gov/pubmed/36156448
http://dx.doi.org/10.1016/j.esmoop.2022.100535
_version_ 1784797920286998528
author Zhang, J.
Liu, L.
Wang, G.
Zhao, K.
Guo, C.
Li, S.
author_facet Zhang, J.
Liu, L.
Wang, G.
Zhao, K.
Guo, C.
Li, S.
author_sort Zhang, J.
collection PubMed
description
format Online
Article
Text
id pubmed-9512834
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95128342022-09-28 Letter re: Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study Zhang, J. Liu, L. Wang, G. Zhao, K. Guo, C. Li, S. ESMO Open Correspondence Elsevier 2022-09-23 /pmc/articles/PMC9512834/ /pubmed/36156448 http://dx.doi.org/10.1016/j.esmoop.2022.100535 Text en © 2022 Published by Elsevier Ltd on behalf of European Society for Medical Oncology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correspondence
Zhang, J.
Liu, L.
Wang, G.
Zhao, K.
Guo, C.
Li, S.
Letter re: Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study
title Letter re: Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study
title_full Letter re: Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study
title_fullStr Letter re: Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study
title_full_unstemmed Letter re: Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study
title_short Letter re: Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study
title_sort letter re: neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage iii/n2 non-small-cell lung cancer: a retrospective single-center cohort study
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512834/
https://www.ncbi.nlm.nih.gov/pubmed/36156448
http://dx.doi.org/10.1016/j.esmoop.2022.100535
work_keys_str_mv AT zhangj letterreneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudy
AT liul letterreneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudy
AT wangg letterreneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudy
AT zhaok letterreneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudy
AT guoc letterreneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudy
AT lis letterreneoadjuvantchemoradiotherapyissuperiortochemotherapyaloneinsurgicallytreatedstageiiin2nonsmallcelllungcanceraretrospectivesinglecentercohortstudy